Use of Electrocardiogram Monitoring in Adult Patients Taking High-Risk QT Interval Prolonging Medicines in Clinical Practice: Systematic Review and Meta-analysis-Reference-Cited by-同舟云学术

Use of Electrocardiogram Monitoring in Adult Patients Taking High-Risk QT Interval Prolonging Medicines in Clinical Practice: Systematic Review and Meta-analysis

Published:2022-08-10 Issue:10 Volume:45 Page:1037-1048
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Saf

Author:

Putnikovic Marijana^ORCID,Jordan Zoe,Munn Zachary,Borg Corey,Ward Michael

Funder

The University of Adelaide

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Link

https://link.springer.com/content/pdf/10.1007/s40264-022-01215-x.pdf

Reference51 articles.

1. Straus SM, et al. Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death. Eur Heart J. 2005;26(19):2007–12.

2. Schwartz PJ, Woosley RL. Predicting the unpredictable: drug-induced QT prolongation and torsades de pointes. J Am Coll Cardiol. 2016;67(13):1639–50.

3. QT interval and drug therapy. BMJ. 2016;353:i2732.

4. Jardin CG, Putney D, Michaud S. Assessment of drug-induced torsade de pointes risk for hospitalized high-risk patients receiving QT-prolonging agents. Ann Pharmacother. 2014;48(2):196–202.

5. Trinkley KE, et al. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians. Curr Med Res Opin. 2013;29(12):1719–26.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Determining sensitivity and specificity of risk scores for QTc interval prolongation in hemato-oncology patients prescribed systemic antifungal therapy: a retrospective cross-sectional study;International Journal of Clinical Pharmacy;2024-08-14

2. Risk of corrected QT interval prolongation in patients receiving antipsychotics;International Clinical Psychopharmacology;2024-07-31

3. Conundrum of Clinical QTc Monitoring;Drug Safety;2022-08-26